Peptides for Muscle Recovery: BPC-157, TB-500 and More

EXOMA Scientific Team · Publicado el 5 de enero de 2026 · Actualizado el 24 de agosto de 2026

Complete guide on regenerative peptides. Mechanisms of action, effective combinations and applications in injury research.

Regenerative Peptides: General Framework

Regenerative peptides are amino-acid sequences that modulate endogenous tissue-repair processes —angiogenesis, cell migration, extracellular matrix remodeling, and resolution of the inflammatory response.

BPC-157 (Body Protection Compound)

Origin and structure

Pentadecapeptide fragment (15 aa) derived from a human gastric protein. Stable at gastric pH, which allows study by the oral and subcutaneous routes in animal models.

Mechanisms described in the preclinical literature

• Directed angiogenesis through upregulation of VEGF-R2.
• Modulation of the nitric oxide (NO) axis, relevant in local perfusion of the injured tissue.
• Increased expression of growth factors (FGF-2, EGR-1) in repair areas.
• Stabilization of tight junctions in digestive epithelium (models of NSAID-induced injury).

Ranges in animal research

TB-500 (synthetic fragment of Thymosin Beta-4)

Mechanism

• G-actin sequestration via Ac-SDKP, regulating cytoskeletal dynamics.
• Accelerated cell migration of keratinocytes, endothelial cells, and satellite myocytes.
• Attenuation of inflammation via inhibition of NF-κB in ischemic models.

Studied ranges

BPC-157 + TB-500 combination: rational basis

1. BPC-157 promotes local neovascularization and matrix stability.
2. TB-500 facilita migración de células reparadoras al sitio neovascularizado.
3. Modulan distintas vías inflamatorias (NO vs NF-κB).

It is investigated in animal models of Achilles tendinopathy, meniscal injury and post-surgical skin repair.

Other related regenerative peptides

• GHK-Cu: extracellular matrix remodeling, collagen I/III expression.
• MOTS-c: mitochondrial peptidomics, AMPK modulation.
• Thymosin alpha-1: immunomodulation (not to be confused with TB-500).

Analytical purity

Reproducible research requires HPLC ≥99%, mass spectrometry for identity, endotoxins by LAL <0.25 EU/mg. EXOMA delivers a traceable per-batch COA.

References

1. Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des. 2014;20(7):1126-1135. doi:10.2174/13816128113190990411. PMID 23755725. (revisión)

1. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. doi:10.1517/14712598.2012.634793. PMID 22074294. (review)

1. Crockford D, Turjman N, Allan C, Angel J. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010;1194:179-189. doi:10.1111/j.1749-6632.2010.05492.x. PMID 20536467. (review)

Products available at EXOMA

• BPC-157
• BPC-157 + TB-500
• TB-500